| Autor: |
Alb M; Medizinische Klinik und Poliklinik II, Lehrstuhl für Zelluläre Immuntherapie, Universitätsklinikum Würzburg, Würzburg, Germany., Reiche K; Fraunhofer-Institut für Zelltherapie und Immunologie IZI, Leipzig, Germany., Rade M; Fraunhofer-Institut für Zelltherapie und Immunologie IZI, Leipzig, Germany., Sewald K; Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM, Hannover, Germany., Loskill P; Institute for Biomedical Engineering, Eberhard Karls University Tübingen, Tübingen, Germany.; 3R-Center for In vitro Models and Alternatives to Animal Testing, Eberhard Karls University Tübingen, Tübingen.; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Cipriano M; Institute for Biomedical Engineering, Eberhard Karls University Tübingen, Tübingen, Germany.; 3R-Center for In vitro Models and Alternatives to Animal Testing, Eberhard Karls University Tübingen, Tübingen., Maulana TI; Institute for Biomedical Engineering, Eberhard Karls University Tübingen, Tübingen, Germany.; 3R-Center for In vitro Models and Alternatives to Animal Testing, Eberhard Karls University Tübingen, Tübingen., van der Meer AD; Applied Stem Cell Technologies, University of Twente, Enschede, the Netherlands., Weener HJ; Applied Stem Cell Technologies, University of Twente, Enschede, the Netherlands., Clerbaux LA; European Commission, Joint Research Centre (JRC), Ispra, Italy., Fogal B; Department on Nonclinical Drug Safety, Boehringer Ingelheim Pharmaceutical, Inc, Ridgefield, CT, USA., Patel N; Preclinical Safety, Research and Development, Sanofi-Aventis US, LLC, Cambridge, MA, USA., Adkins K; Preclinical Safety, Research and Development, Sanofi-Aventis US, LLC, Cambridge, MA, USA., Lund E; Labcorp Drug Development Inc, Derbyshire, UK., Perkins E; Labcorp Drug Development Inc, Derbyshire, UK., Cooper C; Labcorp Drug Development Inc, Derbyshire, UK., van den Brulle J; T-CURX GmbH, Würzburg, Germany., Morgan H; Novartis Biomedical Research, Novartis Campus, Basel, Switzerland., Rubic-Schneider T; Novartis Biomedical Research, Novartis Campus, Basel, Switzerland., Ling H; Novartis Biomedical Research, Cambridge, MA, USA., DiPetrillo K; Novartis Biomedical Research, Cambridge, MA, USA., Moggs J; Novartis Biomedical Research, Novartis Campus, Basel, Switzerland., Köhl U; Fraunhofer-Institut für Zelltherapie und Immunologie IZI, Leipzig, Germany., Hudecek M; Medizinische Klinik und Poliklinik II, Lehrstuhl für Zelluläre Immuntherapie, Universitätsklinikum Würzburg, Würzburg, Germany.; Fraunhofer-Institut für Zelltherapie und Immunologie IZI, Leipzig, Germany. |
